Monday, July 02, 2012

GlaxoSmithKline to pay $3 billion in fraud case

GlaxoSmithKline [GSK] has agreed to plead guilty to misdemeanor criminal charges and to pay $3 billion to settle a fraud case involving drugs Avandia, Paxil and Wellbutrin.

One of the issues was the distribution of a misleading medical journal article.

See GlaxoSmithKline settles fraud case for $3 billion .

The CBS Evening News on July 2 had quotes from Carmen Ortiz on the case. Between 1998-2003, GSK pushed Paxil for treating depression in children, although the FDA never approved Paxil for this use.

Pelley asked if the doctors taking bribes were being prosecuted. To date, no individual GSK employees have been charged.


Post a Comment

<< Home